All
  • All
  • Company News
  • Press Releases
Four people standing in front of a screen holding certificates.

Porton At DCAT Week 2023: A Highly Successful And Strategic Event

          NEW YORK, NY - On March 20th through March 23rd, 2023, Midtown New York City was...
Esg awards - esg awards - esg awards - esg awards - e.

Porton Released 2022 CSR Report

Porton Pharma Solutions Ltd. recently released 2022 CSR Report which is its seventh CSR report since IPO. This report demonstrates the company's ideas and achievements...
Porton logo on a white background.

Porton Delivers Strong 2022 Performance With 127% Sales Growth

In 2022, Porton delivers RMB 7 billion revenue and 127% revenue growth. Net profit attributable to shareholders of the listed company increased 283% to RMB...
Sap global esg score 2020.

Porton Gets Above-Average S&P Global Environmental, Social, And Governance (ESG) Score

Porton Pharma Solutions Ltd. is proud to announce that it has made the top quartile of the S&P Corporate Sustainability Assessment for the first time....
Porton cdmo award 2021.

Porton Pharma Solutions Recognized By Roche Group As A Leading CDMO Service Provider

Porton’s recognition by Roche is a testament to the high-quality service and technical expertise that comes with working with a leading global...
1661976056667

AAPS Annual Meeting at the Boston Convention Center on October 16th – 19th

J-Star Research and Porton Pharma Solutions Ltd. are excited to be exhibiting at this year’s American Association of Pharmaceutical Scientists (AAPS) Annual Meeting at the Boston Convention Center on October...
A large building with a grassy field in front of it.

Porton Reports Strong Interim Results 2022

The year 2022 is an important milestone for Porton. Despite of the uncertainties of the external environment, we always keep in mind...
e760e0eb-251d-4858-85d1-1a59ea0dadf0

Porton Pharma Solutions Ltd. to Expand Operations in Europe

PORTON PHARMA SOLUTIONS LTD., a world leading CDMO (Hereafter PORTON) announces plans to invest into a new state of the Art cGMP/API facility inside, Life...
Four men standing in front of a novartis sign.

Porton Pharma Solutions Ltd. To Expand Operations In Europe

PORTON PHARMA SOLUTIONS LTD., a world leading CDMO (Hereafter PORTON) announces plans to invest into a new state of the Art cGMP/API...
new-facility

New State-of-the-Art Crystallization and Drug Product Facility

Porton is excited to announce construction of a new, state-of-the-art Crystallization and Drug Product facility in Cranbury, NJ. The new building is projected to open...
pharma-crystallization-summit-2022-technical-program-now-available

Pharma Crystallization Summit 2022 Technical Program Now Available

We are very excited to announce the technical program of Pharma Crystallization Summit 2022. This year’s Summit is in-person only and the seats are limited....
metastx-llc-raises-funds-engages-j-star-research-as-manufacturing-partner-and-advances-phase-one-development

MetasTx LLC Raises Funds, Engages J-STAR Research as Manufacturing Partner, and Advances Phase One Development

BASKING RIDGE, N.J., June 07, 2022 (GLOBE NEWSWIRE) -- MetasTx LLC is driven to create novel therapeutics to treat and prevent metastasis of cancers. Harvey Homan, CEO...